Skip to main content

Official Journal of the Italian Society of Orthopaedics and Traumatology

Table 1 Baseline characteristics of the included studies

From: Hormone replacement therapy in women and risk of carpal tunnel syndrome: a systematic review and metaanalysis

Author, year

Country

Study design

Total population

Carpal tunnel syndrome, n (%)

HRT used in case, n (%)

HRT used in control, n (%)

Age (mean ± SD)

Duration of HRT used, year (median, IQR)

Type of HRT

Adjusted data

Tang, 2022 [6]

Taiwan

Case–control

118,309

4535 (3.8)

2,334 (51.5)

31,958 (28.1)

51

N/A

N/A

Yes

Rousan, 2018 [7

USA

Randomized-control trial

16,053

841 (5.2)

376 (44.7)

7704 (50.6)

65.9 ± 5.6

No

 CEE trial

6,833

465 (6.8)

203 (43.6)

3177 (49.8)

65.7 ± 6

7.2 (6.4, 8.1)

CEE

No

 EP trial

9,220

376 (4.1)

173 (46)

4527 (51.2)

66.2 ± 5.4

5.6 (4.8, 6.5)

EP

Yes

Ricco, 2016 [14]

Italy

Cross sectional

631

48 (7.6)

39 (81.2)

264 (45.2)

38.1 ± 7.8

 > 5

N/A

Yes

Geoghegan, 2004 [16

UK

Case–control

16,955

3391 (20)

556 (16.4)

1799 (13.3)

46 ± 20

N/A

N/A

Yes

Ferry, 2000 [15]

England

Nested case–control

2528

1264 (50)

61 (4.8)

47 (3.7)

41.9

N/A

N/A

No

Solomon, 1999 [11

USA

Case–control

115,205

627 (16.7)

5 (0.7)

3 (0.8)

73% over 64 years old

N/A

N/A

Yes

Dieck, 1985 [13]

USA

Case–control

1083

40 (3.8)

21 (52.5)

329 (31.5)

Range 45–74 years old

N/A

N/A

No

  1. HRT hormone replacement therapy, N/A not available, SD standard deviation, IQR interquartile range, CEE conjugated equine estrogen, EP estrogen and progestin